ANIP vs EIX · rev $614.4M vs P/E 7.3, rev $17.60B
ANI Pharmaceuticals Inc (ANIP) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ANIP revenue for 2024-12-31 was $614.4M. Net income was -$18.5M. Revenue was up 26.2% from 2023-12-31 to 2024-12-31. ANIP currently screens at market cap $1.41B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ANIP currently screens at market cap $1.41B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ANIP and EIX stock pages for the full models.
Not investment advice.